Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from WST

Sold for $88,888,888: huge subdivision sells mid-development

The project will see about 1600 homes erected in Bellbird North.

Newcastle Herald

3 Dividend-Paying Stocks Becoming Popular Among Bargain Hunters

3 Dividend-Paying Stocks Becoming Popular Among Bargain Hunters

As inflation hit above estimated levels in June, growing concerns over the Fed’s aggressive interest rate hikes and a consequent recession drove a sell-off this week. Since the market volatility is not expected to lessen soon, dividend-paying stocks West Pharmaceutical (WST), S&P Global (SPGI), and Sherwin-Williams (SHW), currently trading at…

Mixed doubles snooker event to take place in Milton Keynes in September

Mixed doubles snooker event to take place in Milton Keynes in September

The world’s top four men will each be paired by the top four women in a new event.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Snooker star banned for playing drunk and making inappropriate comments to female staff

English player Jamie O'Neill has paid a heavy penalty at the hands of the World Snooker Tour for turning up at a qualifying match in Leicester under the influence of alcohol

West Pharmaceutical Services Shares Slides Post Q1 Results

West Pharmaceutical Services Inc (NYSE:WST) reported first-quarter FY22 sales growth of 7.4% year-on-year to $720 million, missing the consensus of $720.92 million. Proprietary products segment revenue grew 10.6% Y/Y to $601.3 million. Contact-manufactured products segment sales declined 6.6% to $118.7 million. Gross profit margin fell 100 basis points to 40%, and the gross…

West Pharmaceutical Servs: Q1 Earnings Insights

West Pharmaceutical Servs (NYSE:WST) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

3 Beaten-Down Growth Stocks to Snatch Up in Q2 2022

Despite no clarity on when the Russia-Ukraine war will end, surging inflation, and logistical hindrances, the U.S. economy looks sufficiently resilient to weather the crises. Given this backdrop, we think shares of beaten-down growth stocks IQVIA (IQV), West Pharmaceutical (WST), and Synopsys (SNPS) could soar in price in the coming…

inkl

Read news from The Economist, FT, and more,
with one subscription

Ominous Death Cross Forms On West Pharmaceutical Servs's Chart

Ominous Death Cross Forms On West Pharmaceutical Servs's Chart

If history is any guide, there may be trouble ahead for shares of West Pharmaceutical Servs (NYSE:WST). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Take Advantage of the Dip and Buy These 4 Beaten-Down Healthcare Stocks

Take Advantage of the Dip and Buy These 4 Beaten-Down Healthcare Stocks

The healthcare industry is expected to achieve solid growth with rising investments in the sector and soaring demand from an aging population. Therefore, we think it could be wise to bet on beaten-down healthcare stocks West Pharmaceutical (WST), Bio-Rad Laboratories (BIO), Quest Diagnostics (DGX), and Masimo Corporation (MASI), which possess…

West Pharmaceutical's Q4 Performance Surpass Expectations, Expects FY22 Sales To Increase 8%

West Pharmaceutical's Q4 Performance Surpass Expectations, Expects FY22 Sales To Increase 8%

West Pharmaceutical Services Inc's (NYSE: WST) Q4 net s

5 Top-Rated Growth Stocks to Buy for February

5 Top-Rated Growth Stocks to Buy for February

Major benchmark stock indexes have been hit hard this month on concerns over high inflation and the Fed’s decision to raise interest rates. However, following fourth-quarter GDP growth, a promising economic outlook should help growth-focused companies perform well this year. Therefore, we think it could be wise to bet on…

3 Oversold Medical Equipment and Device Stocks to Scoop Up Right Now

3 Oversold Medical Equipment and Device Stocks to Scoop Up Right Now

A growing demand for early medical diagnosis is driving the market for advanced medical equipment by healthcare centers and hospitals. Also, increasing spending on research & development by medical technology companies to deliver innovative technology is helping the industry rebound. So, we think the recent price dips in the stocks…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Renewable Energy

Places

253,443 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play